Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glial cell line-derived neurotrophic factor family receptor alpha (GFRα) refers to a family of glycosylphosphatidylinositol (GPI)-anchored cell surface receptors that serve as co-receptors for the GDNF family ligands (GFLs), including glial cell line-derived neurotrophic factor (GDNF), neurturin, artemin, and persephin. Upon ligand binding, the complex recruits and activates RET tyrosine kinase receptor, triggering downstream signaling pathways that promote neuronal survival, differentiation, growth, and maintenance. GFRα receptors are involved in various biological processes including neuronal development, kidney development, and spermatogenesis. Abnormal expression or activation can contribute to tumorigenesis and developmental disorders.
Ligand binding to GFRα recruits and activates the RET tyrosine kinase receptor, triggering downstream signaling pathways such as MAPK/ERK and PI3K/AKT to promote neuronal survival, differentiation, growth, and maintenance. Can also interact with NCAM to activate alternative signaling cascades independent of RET activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glial Cell-Line Derived Neurotrophic Factor Family Receptor Alpha (GFRα).